Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia

Juvenile myelomonocytic leukemia is a rare myeloproliferative disease in young children. While hematopoietic stem cell transplantation remains the only curative therapeutic option for most patients, children with juvenile myelomonocytic leukemia increasingly receive novel agents in phase I–II clinic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Niemeyer, Charlotte M., Loh, Mignon L., Cseh, Annamaria, Cooper, Todd, Dvorak, Christopher C., Chan, Rebecca, Xicoy, Blanca, Germing, Ulrich, Kojima, Seiji, Manabe, Atsushi, Dworzak, Michael, De Moerloose, Barbara, Starý, Jan, Smith, Owen P., Masetti, Riccardo, Catala, Albert, Bergstraesser, Eva, Ussowicz, Marek, Fabri, Oskana, Baruchel, André, Cavé, Hélène, Zwaan, Michel, Locatelli, Franco, Hasle, Henrik, van den Heuvel-Eibrink, Marry M., Flotho, Christian, Yoshimi, Ayami
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2015
Matèries:
Guideline Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4281308/
https://ncbi.nlm.nih.gov/pubmed/25552679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.109892
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars